Patents by Inventor Pascal Derkinderen

Pascal Derkinderen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160186233
    Abstract: The present invention provides materials and methods relating to screening for compounds useful in the treatment of Alzheimer's disease and related conditions. In particular, screening methods using tyrosine kinases are provided, as are methods relating to the role of tyrosine kinases as therapeutic targets.
    Type: Application
    Filed: August 17, 2015
    Publication date: June 30, 2016
    Applicants: Proteome Sciences plc, King's College London
    Inventors: Malcolm Ward, Helen Byers, Brian Henry Anderton, Pascal Derkinderen, Christopher Hugh Reynolds, Ritchie Williamson
  • Patent number: 8367360
    Abstract: The present invention provides methods of screening for candidate compounds useful in the treatment of Alzheimer's disease and related conditions by inhibiting specific phosphorylation of tau protein by tyrosine kinase c-Abl.
    Type: Grant
    Filed: June 21, 2005
    Date of Patent: February 5, 2013
    Assignees: Proteome Sciences plc, King's College London
    Inventors: Malcolm Ward, Helen Byers, Brian Henry Anderton, Pascal Derkinderen, Christopher Hugh Reynolds, Ritchie Williamson
  • Publication number: 20080103107
    Abstract: The present invention provides materials and methods relating to screening for compounds useful in the treatment of Alzheimer's disease and related conditions. In particular, screening methods using tyrosine kinases are provided, as are methods relating to the role of tyrosine kinases as therapeutic targets.
    Type: Application
    Filed: June 21, 2005
    Publication date: May 1, 2008
    Inventors: Malcolm Ward, Helen Byers, Brain Henry Anderton, Pascal Derkinderen, Christopher Hugh Reynolds, Ritchie Williamson